MX347828B - Fenil-3-aza-biciclo[3,1,0]hex-3-il-metanonas y su uso como medicamento. - Google Patents
Fenil-3-aza-biciclo[3,1,0]hex-3-il-metanonas y su uso como medicamento.Info
- Publication number
- MX347828B MX347828B MX2014001252A MX2014001252A MX347828B MX 347828 B MX347828 B MX 347828B MX 2014001252 A MX2014001252 A MX 2014001252A MX 2014001252 A MX2014001252 A MX 2014001252A MX 347828 B MX347828 B MX 347828B
- Authority
- MX
- Mexico
- Prior art keywords
- compounds
- methanones
- aza
- bicyclo
- hex
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Las presentes invenciones se refiere a fenil-3-aza-biciclo[3, 1 ,0]hex3-il-metanonas sustituidas de la fórmula general (I) (ver Fórmula) en donde R1, R2, R3, R4, R5 y R6 son como se describen en la presente o sus sales, con preferencia, sus sales farmacéuticamente aceptables. La invención también se refiere a la preparación de dichos compuestos, composiciones farmacéuticas que comprenden un compuesto de acuerdo con la fórmula general (I) y el uso de dichos compuestos para el tratamiento de diversas condiciones tales como condiciones referidas a síntomas positivos y negativos de esquizofrenia, así como las alteraciones cognitivas asociadas con esquizofrenia, enfermedad de Alzheimer y otros trastornos neurológicos y psiquiátricos. Los compuestos de la invención muestran propiedades inhibidoras del transportador de glicina 1 (GIyT1).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11176468 | 2011-08-03 | ||
PCT/EP2012/065140 WO2013017657A1 (en) | 2011-08-03 | 2012-08-02 | Phenyl-3-aza-bicyclo[3.1.0]hex-3-yl-methanones and the use thereof as medicament |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2014001252A MX2014001252A (es) | 2014-05-13 |
MX347828B true MX347828B (es) | 2017-05-15 |
Family
ID=46598566
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2014001252A MX347828B (es) | 2011-08-03 | 2012-08-02 | Fenil-3-aza-biciclo[3,1,0]hex-3-il-metanonas y su uso como medicamento. |
Country Status (37)
Country | Link |
---|---|
US (1) | US9012489B2 (es) |
EP (1) | EP2739615B1 (es) |
JP (1) | JP5850589B2 (es) |
KR (1) | KR101944686B1 (es) |
CN (2) | CN103797005B (es) |
AP (1) | AP2014007399A0 (es) |
AR (1) | AR087436A1 (es) |
AU (1) | AU2012292036C1 (es) |
BR (1) | BR112014001642B1 (es) |
CA (1) | CA2843805C (es) |
CL (1) | CL2014000246A1 (es) |
CO (1) | CO6870037A2 (es) |
CY (1) | CY1119326T1 (es) |
DK (1) | DK2739615T3 (es) |
EA (1) | EA024933B1 (es) |
EC (1) | ECSP14013221A (es) |
ES (1) | ES2623006T3 (es) |
GE (1) | GEP20166483B (es) |
HK (1) | HK1193100A1 (es) |
HR (1) | HRP20170695T1 (es) |
HU (1) | HUE033134T2 (es) |
IL (1) | IL229962A (es) |
LT (1) | LT2739615T (es) |
MA (1) | MA35286B1 (es) |
ME (1) | ME02672B (es) |
MX (1) | MX347828B (es) |
MY (1) | MY167396A (es) |
PE (1) | PE20141352A1 (es) |
PL (1) | PL2739615T3 (es) |
PT (1) | PT2739615T (es) |
RS (1) | RS55927B1 (es) |
SI (1) | SI2739615T1 (es) |
TN (1) | TN2014000044A1 (es) |
TW (1) | TWI543974B (es) |
UA (1) | UA114405C2 (es) |
UY (1) | UY34239A (es) |
WO (1) | WO2013017657A1 (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR122021017872B1 (pt) | 2014-06-06 | 2021-11-23 | Basf Se | Uso dos compostos, composição agroquímica e método para o combate dos fungos fitopatogênicos |
AR106679A1 (es) | 2015-11-13 | 2018-02-07 | Basf Se | Oxadiazoles sustituidos para combatir hongos fitopatógenos |
EP3373735A1 (en) | 2015-11-13 | 2018-09-19 | Basf Se | Substituted oxadiazoles for combating phytopathogenic fungi |
KR20180083419A (ko) | 2015-11-19 | 2018-07-20 | 바스프 에스이 | 식물병원성 진균을 퇴치하기 위한 치환 옥사디아졸 |
US10986839B2 (en) | 2016-04-11 | 2021-04-27 | Basf Se | Substituted oxadiazoles for combating phytopathogenic fungi |
WO2018224455A1 (en) | 2017-06-07 | 2018-12-13 | Basf Se | Substituted cyclopropyl derivatives |
EA202192925A1 (ru) | 2019-05-01 | 2022-03-23 | Бёрингер Ингельхайм Интернациональ Гмбх | Твердые формы ингибитора glyt1 |
CN116212025A (zh) | 2020-01-09 | 2023-06-06 | 迪斯克医药公司 | 治疗红细胞生成性原卟啉病、x连锁原卟啉病或先天性红细胞生成性卟啉病的方法 |
JP2023537963A (ja) | 2020-08-13 | 2023-09-06 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 統合失調症に伴う認知機能障害に対する処置法 |
WO2022078927A1 (en) | 2020-10-13 | 2022-04-21 | Boehringer Ingelheim International Gmbh | Process of reworking |
WO2023097276A1 (en) * | 2021-11-24 | 2023-06-01 | Maplight Therapeutics, Inc. | Methods of treating neurological disorders |
CN114957087A (zh) * | 2022-04-13 | 2022-08-30 | 湖南复瑞生物医药技术有限责任公司 | 一种帕罗韦德中间体制备方法 |
TW202348602A (zh) * | 2022-06-10 | 2023-12-16 | 大陸商成都百裕製藥股份有限公司 | 吡咯烷衍生物、藥物组合物及其製藥用途 |
WO2024042043A1 (en) | 2022-08-24 | 2024-02-29 | Boehringer Ingelheim International Gmbh | A scalable process for the preparation of a glyt-1 inhibitor |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE362364T1 (de) | 2003-04-10 | 2007-06-15 | Ranbaxy Lab Ltd | Substituierte azabicyclo hexane derivate als muscarin rezeptor antagonisten |
NZ546012A (en) * | 2003-10-14 | 2009-12-24 | Pfizer Prod Inc | Bicyclic [3.1.0] derivatives as glycine transporter inhibitors |
DE102004035280A1 (de) | 2004-07-21 | 2006-03-16 | Robert Bosch Gmbh | Kraftstoffinjektor mit direkter mehrstufiger Einspritzventilgliedansteuerung |
CA2593453A1 (en) * | 2005-01-06 | 2006-07-13 | F. Hoffmann-La Roche Ag | Sulfanyl substituted phenyl methanones as glycine transporter 1 (glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders |
CA2593463C (en) * | 2005-01-07 | 2013-10-08 | F. Hoffmann-La Roche Ag | [4-(heteroaryl) piperazin-1-yl]-(2,5-substituted -phenyl)methanone derivatives as glycine transporter 1 (glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders |
MX2007009342A (es) * | 2005-02-07 | 2007-09-21 | Hoffmann La Roche | Fenil-metanonas sustituidas por heterociclo como inhibidor del transportador 1 de glicina. |
CA2653355C (en) * | 2006-06-22 | 2014-04-15 | F. Hoffmann-La Roche Ag | Substituted phenyl methanone derivatives |
KR101288781B1 (ko) | 2006-06-28 | 2013-07-22 | 암젠 인크 | 글리신 수송자-1 억제제 |
TW200833328A (en) * | 2006-12-28 | 2008-08-16 | Actelion Pharmaceuticals Ltd | 2-aza-bicyclo[3.1.0]hexane derivatives |
UA105362C2 (en) | 2008-04-02 | 2014-05-12 | Бьорингер Ингельхайм Интернациональ Гмбх | 1-heterocyclyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a modulators |
KR20110117087A (ko) * | 2008-12-29 | 2011-10-26 | 벤더르빌트 유니버시티 | 3.1.0 비시클릭 glyt1 억제제 및 그것을 제조 및 사용하는 방법 |
UA104611C2 (en) | 2009-01-27 | 2014-02-25 | Ф. Хоффманн-Ля Рош Аг | Aroylamino- and heteroaroylamino-substituted piperidines as glyt-1 inhibitors |
-
2012
- 2012-07-27 US US13/560,063 patent/US9012489B2/en active Active
- 2012-08-01 TW TW101127831A patent/TWI543974B/zh active
- 2012-08-02 BR BR112014001642-9A patent/BR112014001642B1/pt active IP Right Grant
- 2012-08-02 LT LTEP12741022.3T patent/LT2739615T/lt unknown
- 2012-08-02 AR ARP120102828 patent/AR087436A1/es active IP Right Grant
- 2012-08-02 PT PT127410223T patent/PT2739615T/pt unknown
- 2012-08-02 AU AU2012292036A patent/AU2012292036C1/en active Active
- 2012-08-02 JP JP2014523332A patent/JP5850589B2/ja active Active
- 2012-08-02 WO PCT/EP2012/065140 patent/WO2013017657A1/en active Application Filing
- 2012-08-02 DK DK12741022.3T patent/DK2739615T3/en active
- 2012-08-02 UA UAA201402017A patent/UA114405C2/uk unknown
- 2012-08-02 CN CN201280042794.7A patent/CN103797005B/zh active Active
- 2012-08-02 SI SI201230968A patent/SI2739615T1/sl unknown
- 2012-08-02 EA EA201400183A patent/EA024933B1/ru not_active IP Right Cessation
- 2012-08-02 KR KR1020147002515A patent/KR101944686B1/ko active IP Right Grant
- 2012-08-02 CA CA2843805A patent/CA2843805C/en active Active
- 2012-08-02 CN CN201610214305.1A patent/CN105837562B/zh active Active
- 2012-08-02 ME MEP-2017-92A patent/ME02672B/me unknown
- 2012-08-02 MX MX2014001252A patent/MX347828B/es active IP Right Grant
- 2012-08-02 ES ES12741022.3T patent/ES2623006T3/es active Active
- 2012-08-02 MY MYPI2014000271A patent/MY167396A/en unknown
- 2012-08-02 HU HUE12741022A patent/HUE033134T2/en unknown
- 2012-08-02 EP EP12741022.3A patent/EP2739615B1/en active Active
- 2012-08-02 RS RS20170472A patent/RS55927B1/sr unknown
- 2012-08-02 GE GEAP201213402A patent/GEP20166483B/en unknown
- 2012-08-02 PL PL12741022T patent/PL2739615T3/pl unknown
- 2012-08-02 PE PE2014000158A patent/PE20141352A1/es active IP Right Grant
- 2012-08-02 AP AP2014007399A patent/AP2014007399A0/xx unknown
- 2012-08-03 UY UY34239A patent/UY34239A/es unknown
-
2013
- 2013-12-17 IL IL229962A patent/IL229962A/en active IP Right Grant
-
2014
- 2014-01-31 MA MA36719A patent/MA35286B1/fr unknown
- 2014-01-31 CL CL2014000246A patent/CL2014000246A1/es unknown
- 2014-01-31 TN TNP2014000044A patent/TN2014000044A1/en unknown
- 2014-02-03 CO CO14022058A patent/CO6870037A2/es active IP Right Grant
- 2014-02-26 EC ECSP14013221 patent/ECSP14013221A/es unknown
- 2014-07-02 HK HK14106631.6A patent/HK1193100A1/zh unknown
-
2017
- 2017-05-10 HR HRP20170695TT patent/HRP20170695T1/hr unknown
- 2017-06-06 CY CY20171100591T patent/CY1119326T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TN2014000044A1 (en) | Phenyl-3-aza-bicyclo[3.1.0]hex-3-yl-methanones and the use thereof as medicament | |
MX347706B (es) | Derivados de triazol y su uso para trastornos neurologicos. | |
MY158974A (en) | Prodrugs comprising an exendin linker conjugate | |
MX2020010151A (es) | Analogos de piridazina 1,4-disustituida y metodos para el tratamiento de condiciones relacionadas con la deficiencia de smn. | |
TN2012000011A1 (en) | Prodrugs comprising an insulin linker conjugate | |
MX2012012952A (es) | Compuestos de 2, 5, 6, 7,-tetrahidro-[1, 4] oxazepin-3-ilamina o 2, 3, 6, 7-tetrahidro-[1, 4] oxazepin-5-ilamina. | |
UA113051C2 (xx) | Гетероциклічні похідні та їх застосування у лікуванні неврологічних розладів | |
MX2012007273A (es) | Pteridinonas como inhibidores de la quinasa tipo polo. | |
BR112015028452A2 (pt) | agonistas do receptor somastatina subtipo 4 (sstr4) | |
EA201592146A1 (ru) | Гетероароматические соединения и их применение в качестве лигандов к дофаминовым d1-рецепторам | |
MX2013011589A (es) | Metodos y composiciones para tratar enfermedad de parkinson. | |
SI2875011T1 (en) | 5-HT3 receptor antagonists | |
MX2013008056A (es) | 1,4-oxazepinas como inhibidores de beta-secretasa 1 (bace1) y/o beta-secretasa 2 (bace2). | |
MX355142B (es) | Acetamidas heterociclicas sustituidas como agonistas del receptor opioide kappa (kor). | |
GEP20135806B (en) | Lactams as beta secretase inhibitors | |
MY183111A (en) | 3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9h-carbazole derivatives and their use as prostaglandin d2 receptor modulators | |
MX345544B (es) | Derivados de triazol como ligandos para receptores de acido gamma-aminobutirico (gaba). | |
WO2011159124A3 (ko) | Interleukin-6 억제 작용을 갖는 신규한 벤즈옥사졸 유도체, 이의 제조 방법 및 이를 포함하는 약학적 조성물 | |
IN2015DN01900A (es) | ||
MX2013005965A (es) | Nuevos compuestos de triazol iii. | |
MX2019015371A (es) | Derivados de dihidro-pirrolo-piridina. | |
MY171743A (en) | Arylethynyl derivatives | |
IN2012DN02005A (es) | ||
EP2593460A4 (en) | ANTI-VIRAL BENZYLAMIDE ANIMIRVENTS OF 4-OXO-4H-PYRIDO [L, 2-A] PYRIMIDINE-2-CARBOXYLIC ACID TO RADICALS NITROGEN IN POSITIONS 7 AND 9 | |
EA201001095A1 (ru) | Соединение (r)-n*6*-этил-6,7-дигидро-5н-индено[5,6-d]тиазол-2,6-диамин и его применение в качестве антипсихотического средства |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |